T&K TOKA Corporation Overview
T&K TOKA is a mid-sized Japanese specialty-ink and functional-materials maker. Its main franchise is ultraviolet (UV)-curable printing inks, a technology it commercialised in 1977. The company describes itself as Japan's market-share leader in UV inks. Bain Capital singled out that leadership as the core of its investment thesis.
Around the ink base sit two adjacent platforms:
Functional resins: epoxy hardeners, latent curing agents and dimer-acid thermoplastic resins.
Precision dispersions: colour-filter pigment dispersions for flat-panel displays, with a dedicated plant in Zhejiang, China.
Overseas operations are Asia-centric, with subsidiaries in Korea, Indonesia, Thailand, China and the US. The company also holds a roughly 30% equity-method stake in Hangzhou Toka Ink, which is listed on Shanghai's STAR Market.
The financial profile is weak. Consolidated revenue fell from ¥49.6bn (FY3/2019) to ¥43.7bn (FY3/2023), and operating margins stayed near 1%. Activist pressure from Dalton/NAVF followed, and in 2024 Bain took the company private. The equity story now rests on a privately executed turnaround under an externally recruited CEO.
Company's own description (FY3/2023 Yuho, paraphrased)
| Product type | Main uses |
|---|---|
| UV inks | Cartons, labels, cards, pamphlets, cans |
| Planographic / offset inks | Posters, catalogues, magazines, flyers |
| Flexographic inks | Labels, paper bags, corrugated boxes |
| Gravure inks | Frozen-food and confectionery bags, publications |
| Metal-decorating inks | Food, beverage and art cans |
| Special functional inks | FPDs, electronic substrates |
| Functional resins | Bridge anti-corrosion paints, automotive adhesives, metal coatings, ink binders, functional films, FRP |
The group makes and sells:
-
printing inks (offset, gravure and others);
-
printing machines and printing-related equipment such as blankets;
-
functional resins;
-
precision dispersion products.
It reports as a single segment ("printing ink business"). No segment-level breakdown is therefore disclosed.
The FY3/2023 Yuho lists seven main product types:
Independent characterisation
| End-market | Stated trend |
|---|---|
| Publication printing | Declining |
| Commercial printing | Flat |
| Package printing | Growing, with sustainability the dominant theme in every field (Yuho FY3/2023) |
T&K TOKA is a B2B formulator and manufacturer. Revenue is overwhelmingly product sales: the FY3/2023 Yuho reports production of ¥32.7bn at selling-price value and purchased merchandise of ¥6.0bn. There is no meaningful subscription or licensing revenue.
The approximate revenue mix (derived, FY3/2023) is:
-
about 85% manufactured products;
-
about 15% traded merchandise such as consumables and equipment (inferred from the purchased-goods figure).
Value-chain position. The company sits in the middle of the chain:
Upstream: it buys pigments, crude-oil derivatives, imported vegetable oils and monomers. Dainichiseika and Nagase are named as purchasing partners in its cross-shareholding disclosure.
Downstream: it sells inks to printers and converters (commercial, label, carton and flexible-packaging printers, can makers). It sells resins to paint, adhesive and composites makers, and dispersions to display-materials supply chains.
Customer types. Shareholdings held "to strengthen sales relationships" provide indirect evidence:
-
printing majors: Dai Nippon Printing, Toppan, Kyodo Printing;
-
packaging printers: Asahi Printing, Nozaki Insatsu Shigyo, Takeda Printing;
-
NISSHA;
-
Kansai Paint (a resin customer);
-
Shobond Holdings (bridge-repair coatings, consistent with anti-corrosion epoxy hardeners);
-
Oji Holdings.
IR Bank's profile lists Nikka Fine Techno and JSR as principal customers, consistent with the display-materials business.
End-markets.
The company also serves electronics/display (colour-filter dispersions, special inks) and industrial coatings/adhesives/composites (resins).
Business model economics
Gross margins sat in a narrow 17–19% band (FY3/2019–FY3/2023, EDINET DB calculation from Yuho data). Operating margins of 0.5–1.1% show that SG&A absorbs nearly all gross profit. Pre-tax profit therefore depended heavily on non-operating income: equity-method income, mainly from Hangzhou Toka Ink, plus dividends from cross-shareholdings and FX gains.
For example, in FY3/2023:
-
operating income was ¥424M;
-
ordinary income was ¥1,853M;
-
the ¥1.43bn gap was largely equity-method and other non-operating income.
This structure, a low-return core business supported by an associate stake and portfolio investments, is central to understanding both the activist campaign and the take-private.
Strategy
Stated strategy (listed era)
| Area | Priorities |
|---|---|
| Inks | EB inks for flexible packaging; UV ink development and sales for labels and cartons; building infrastructure to concentrate on UV |
| Functional materials | Launch the Zhejiang plant; hit new-development targets; raise capacity |
| Foundations | Improve IR quality; IT infrastructure; talent development |
Long-term 2030 Vision (adopted 1 Jan 2021):
-
Mission: provide "truly good products for customers" through "unique technology" and contribute to society.
-
2030 vision: become a global company where individuals and the organisation grow together and are trusted by society.
-
Management policies: customer-centric value creation; supporting and fairly evaluating employees; solving social issues through business.
2030 numerical targets: operating margin 8.0%, ROE 8.0%, payout at least 50% (tender opinion, Jan 2024).
- Three levers: (I) specialise in products that contribute to sustainability; (II) product portfolio reform; (III) shift to problem-solving business models.
Mid-term plan "With You toward 2024" (FY3/2023–FY3/2025):
-
ESG management that balances economic and social value.
-
Allocate operating cash flow preferentially to capex, development and M&A.
-
Strengthen oversight of investments and M&A.
Bain Capital's stated post-acquisition agenda (tender opinion, Jan 2024)
Bain's thesis rested on four strengths it identified:
-
technology and development capability;
-
detailed customer service;
-
customer trust and brand power in Japan and overseas;
-
experienced people.
It committed to:
hands-on management support: through its consulting-style portfolio group;
-
strengthening talent and organisation, drawing on a Japan management-talent pool of more than 100 people;
-
M&A and post-merger integration support, including overseas.
Bain and the company agreed on two priority investment areas: next-generation UV inks and the Zhejiang precision-dispersion business. Bain said existing management would in principle be retained. That was later superseded by the appointment of an external CEO (date not disclosed).
Post-privatisation strategy (company website, 2026)
CEO Ishiai's published message, paraphrased:
-
treat the company as a team sport serving all stakeholders;
-
prioritise a safe, secure and stable foundation;
-
build continuous earning power, sharp-edged technology, rigorous quality and fast execution;
-
support all of this through people development, a "global one team" and a rewarding workplace.
The homepage frames the mission as building a global enterprise that keeps challenging change "through talent development and speedy management reform". Medium-term financial targets are not publicly disclosed since privatisation.
Initiatives register (last 24 months and immediately prior)
| Initiative | Date | Status / target |
|---|---|---|
| Sale of Hangzhou Toka shares below 30% (China mandatory-offer avoidance) | Nov 2023 | Completed; ¥1.95bn proceeds |
| Exit from Russia/Iran-linked business | 2,023 | Completed (tender condition) |
| Withdrawal of seconded officers from Hangzhou Toka; unwinding of certain related-party transactions | 2,023 | Completed (tender condition) |
| Tohoku Toka Shikiso business transfer | Mar 2024 | Completed |
| External CEO recruitment (Ishiai) | Post-2024, date not disclosed | Completed |
| Shift to auditor-based governance with sponsor board | Post-2024 | Completed |
| Parent headcount reduction (636 → 610) | Mar 2023 – Apr 2026 | Ongoing; no programme announced |
| Sustainability: TCFD endorsement; women ≥40% of hires and ≥5% of managers by Mar 2025; 100% parental-leave uptake | Set 2022–2023 | Outcome not publicly disclosed |
| Cost programmes with numerical targets | — | — |
Products & Services
Pricing is not disclosed for any product line. Launch years are given only where documented.
Inks
| Product line | Description / capabilities | Target customers | Launch / latest | Flagship notes |
|---|---|---|---|---|
| General UV inks (UV offset) | Cure instantly under UV light; hard films; print on paper, film and metal | Carton, label, card and commercial printers | First launched 1977; ongoing "new-type UV inks compliant with various regulations" (FY3/2023 R&D) | Company claims No.1 domestic share in UV inks (website meta-description) |
| Special UV inks | High-functionality UV inks; the Yuho singles out special UV inks as the company's strength and priority for capex | Specialty and security printers, can makers | Ongoing | Named as a top priority for operating cash-flow allocation (Yuho MD&A) |
| UV flexo inks | UV-curable flexographic inks with a "global-spec" formulation | Label printers worldwide | FY3/2023 R&D theme | — |
| Low-energy / LED-compatible UV inks | Improved curability under power-saving UV lamps | Printers converting to LED-UV | FY3/2023 R&D theme | Low-energy curability is a stated sustainability lever |
| Low-migration UV inks | For food-contact packaging (Preqin product list) | Food packaging converters | — | — |
| Biomass-mark certified UV inks | Plant-derived content certified under Japan's biomass mark (Preqin product list) | Brand owners with sustainability goals | — | — |
| EB (electron-beam) curable inks | Solvent-free inks for flexible packaging; less odour, higher safety, lower environmental burden than solvent gravure | Flexible-packaging converters | "Environment-friendly EB printing inks" in development (FY3/2023) | Strategic priority in FY3/2024 plan; cited as the shift from solvent ink in tender docs |
| Sheet-fed offset inks | Conventional oil-based lithographic inks | Commercial printers | Mature | Declining market |
| Web (rotary) offset inks | For web presses | Publication/commercial printers | Mature | Declining market |
| Waterless offset inks | For silicone-plate waterless printing | Waterless printers | Mature | — |
| Flexographic inks (solvent / water-based) | For flexible relief plates on paper and film | Label, paper-bag and corrugated converters | Ongoing | Shift to water-based and UV |
| Gravure inks | Intaglio inks for high-volume runs | Food packaging, publications | Ongoing | EB inks positioned as the replacement for solvent gravure |
| Metal-decorating inks | Baked or UV-cured inks on tinplate and aluminium | Can makers (food, beverage, art cans) | Ongoing | — |
| Special functional inks | Inks for electronics, FPDs and circuit boards | Electronics makers | Ongoing | — |
| Primers / metal paints | Coating products (Preqin list) | Industrial | — | — |
Functional materials
| Product line | Description | Target customers | Notes |
|---|---|---|---|
| Colour-filter pigment dispersions | Fine pigment dispersions that improve display colour reproduction | Colour-filter and FPD panel makers (JSR and Nikka Fine Techno cited as principal customers by IR Bank) | Sharp FY3/2023 volume drop on FPD inventory correction; production localised at the Zhejiang plant |
| Nano-dispersion products | Various nano-scale dispersions | Electronics/materials | FY3/2023 R&D "new fields" theme |
| Dispersion × resin-synthesis hybrids | Functional materials combining both core technologies | Industrial | FY3/2023 R&D theme |
| Waterborne epoxy hardeners | Improve the working environment for painting work (low VOC) | Anti-corrosion paint makers (bridge coatings) | Performance enhancement in FY3/2023 |
| Low-temperature latent curing agents | Improve performance of electrical parts and energy efficiency in manufacturing | Electronics adhesive formulators | Performance enhancement in FY3/2023 |
| Epoxy hardeners (general) | Curing agents for epoxy resins | Paint, adhesive and FRP makers | Legacy Fuji Kasei line |
| Dimer-acid thermoplastic resins | Polyamide-type resins from dimerised fatty acids | Ink binders, adhesives | Preqin product list |
| Hydrophobic resins | Water-repellent resins | Coatings | Preqin product list |
| Composite materials | Resin systems for FRP | Composite fabricators | Preqin product list |
| High-performance resins (various) | Petroleum- and bio-based organic synthesis | Ink, paint, adhesive, film makers | Ongoing |
Machinery & consumables
| Product line | Description | Notes |
|---|---|---|
| Printing machines | Printing presses (traded/agency) | Shown as "machine products" on the website |
| Printing-related equipment | Blankets and other consumables | Part of ¥5.96bn purchased merchandise (FY3/2023) |
Financial Narrative
Sources: audited consolidated figures from Yuho FY3/2019–FY3/2023 (EDINET), compiled by EDINET DB. JPY millions unless noted. Japanese GAAP.
Income statement
Supplementary notes:
-
Diluted EPS is not captured in this research. Dilution was immaterial: only 30,400 option shares were outstanding in Jan 2024.
-
FY3/2023 pre-tax income (税金等調整前当期純利益) was ¥1,855M (Yuho cash-flow statement). Other years' pre-tax figures are not captured separately, so ordinary income is shown as the pre-tax proxy.
Revenue CAGR FY3/2019–FY3/2023 (derived): −3.2% per year: EDINET DB's 3-year CAGR is also −3.2%.
- Reference — the longer-run peak: revenue ¥53.0bn in FY3/2013 and operating income ¥2.9bn (6.0% margin) in FY3/2015 (EDINET DB).
Commentary.
-
Revenue. Revenue fell 15% between FY3/2019 and FY3/2021. Causes were structural decline in publication and commercial printing, compounded by COVID-19 in FY3/2021 (−12.5%). FY3/2022 recovered (+5.3%) on price increases and overseas growth. FY3/2023 slipped again (−1.8%): ink sales rose on price pass-through and overseas expansion, but colour-filter dispersion shipments collapsed amid the FPD inventory correction (Yuho FY3/2023 MD&A).
-
Margin compression. Operating margin collapsed from 4.0% (FY3/2018) to 0.7% (FY3/2019) and stayed at or below 1.1% thereafter. The inflection coincides with:
-
the Van Son (Dec 2017) and Midwest Ink (Dec 2018) acquisitions;
-
start-up costs of the Zhejiang dispersion plant;
-
raw-material inflation. The company never recovered its pre-2018 5–6% margin despite repeated price revisions.
-
-
Below-the-line dependence. In every year, ordinary income was 2–9 times operating income. The difference came from equity-method income, mainly Hangzhou Toka, plus dividends and FX. In FY3/2023, equity-method gains of ¥635M were deducted as non-cash in the cash-flow statement.
-
Net income volatility. FY3/2022 net income (¥2.65bn) was boosted by a special gain on the sale of fixed assets at the Hong Kong subsidiary. FY3/2020 (¥158M) was depressed by impairments and other charges, not detailed here. FY3/2023 fell 58% because the HK gain did not recur.
-
Dividends. The FY3/2021 DPS cut to ¥15 (COVID) was reversed to ¥40 in FY3/2022. The FY3/2023 payout ratio reached 81.2% against a medium-term target of at least 50%.
Interim and forecast data for FY3/2024 (last public figures)
Sources: Q3 FY3/2024 results (7 Feb 2024); company notice of 27 Nov 2023. The forecast revision reflected a ¥955M consolidated gain on the Hangzhou Toka share sale.
Interpretation: nine-month operating income rose 52% YoY. This suggests price pass-through and cost actions were gaining traction just as the company went private. Audited FY3/2024 and all later results are not publicly disclosed.
Balance sheet
Notes:
-
The short- vs long-term debt split is not captured in this research. The FY3/2023 Yuho shows short-term borrowings down ¥1,441M, long-term borrowings down ¥740M, and the current portion of long-term debt down ¥68M.
-
The cash figure is "cash and deposits". Cash & equivalents at FY3/2023 was ¥2,828M (Yuho), down ¥3,417M after time-deposit placements and debt repayment.
-
At FY3/2023, PP&E was ¥23,929M and investment securities ¥12,748M. Together (¥36.7bn) they made up 54.1% of total assets (Yuho risk factor 3).
Commentary. The balance sheet was conservative:
-
the equity ratio rose to 71.7%;
-
debt/equity fell to 0.12x;
-
on EDINET DB's "net cash" measure (current assets minus total liabilities), the company held ¥9.9bn.
FY3/2020 borrowing (debt +¥4bn) funded the Zhejiang plant and Midwest Ink and provided COVID liquidity; it was paid down over FY3/2021–FY3/2023.
The key valuation anomaly was that the stock traded at 0.4–0.5x book, and the tender price of ¥1,410 was below BPS of ¥2,136 (30 Jun 2023). The board argued that book value overstated liquidation value because special-purpose plant could not be monetised at carrying value (tender opinion, Jan 2024).
Cash flow
Supplementary items (not available for all five years, so not tabulated):
Capex (accrual): ¥1,358M in FY3/2023, of which Saitama production equipment was ¥544M and the Zhejiang plant build-out ¥407M. Cash purchases of PP&E were ¥1,288M (Yuho FY3/2023).
Dividends paid: ¥1,128M in FY3/2023 (Yuho).
Share buybacks: ¥715M in 2020; ¥1,333M in 2016 (IR Bank). FY3/2023 saw ¥236M of treasury-share purchases via the directors' share-delivery trust (Yuho).
Depreciation & amortisation: ¥2,255M in FY3/2023 (Yuho).
Commentary. Operating cash flow was consistently positive (¥2.1–3.2bn), but trended down. FY3/2023 free cash flow (¥361M) did not cover the ¥1.13bn dividend, so the gap was funded from cash balances. That was unsustainable at a public-company payout of 81%. This is one reason a private owner with lower distribution requirements and a longer horizon was credible.
Ratios
Notes:
- FY3/2020 payout is derived (DPS ¥34 / EPS ¥6.7). EDINET DB leaves it blank.
Interest coverage: and cash conversion cycle are not publicly disclosed in the sources captured. Interest expense was not separately extracted.
Commentary. Capital efficiency was the weakest point. ROE never exceeded 5.8% and averaged about 2.6%. That is far below the company's own 2030 target of 8% and the TSE Prime market's implied cost of equity.
The TSE's 2023 push for companies trading below 1x PBR to address capital efficiency, combined with Dalton/NAVF's 25% stake, made the status quo untenable.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Segment Margins & Growth (%)
| Metric (single segment, JPY Mn) | FY3/2021 | FY3/2022 | FY3/2023 |
|---|---|---|---|
Segment revenue (JPY Mn) | 42,205 | 44,456 | 43,667 |
Segment operating income (JPY Mn) | 198 | 228 | 424 |
Segment operating margin (%) | 0.5 | 0.5 | 1.0 |
Segment revenue YoY growth (%) | -12.5 | 5.3 | -1.8 |
Share of total revenue (%) | 100 | 100 | 100 |
Internal Business Line Details
| Internal business line | Contents | Disclosed revenue |
|---|---|---|
Printing inks | UV (general, special, low-migration, biomass-certified), offset (sheet-fed, web, waterless), flexo (solvent, water-based, UV), gravure, metal-decorating, EB-curable inks | — |
Functional materials — precision dispersions | Colour-filter pigment dispersions, nano-dispersions | Not disclosed. FY3/2023 shipments of CF dispersions "fell sharply" because of FPD oversupply. |
Functional materials — resins | Epoxy hardeners (incl. waterborne), low-temperature latent curing agents, dimer-acid thermoplastic resins, hydrophobic resins, composite materials | — |
Machines & consumables | Printing machines, blankets, printing-related equipment (largely traded merchandise) | Not disclosed. Purchased merchandise was ¥5,959M in FY3/2023, +11.2% YoY. |
“—” = not publicly disclosed.
Group Entities
| Entity | Location | Ownership | Role |
|---|---|---|---|
T&K TOKA Co., Ltd. | Saitama, Japan | Parent | Manufacturing, R&D, sales |
Tohoku Toka Shikiso | Sendai, Japan | 100% | Regional sales (business transferred Mar 2024) |
Korea Special Ink Industry | Incheon, Korea | 100% | Ink manufacturing & sales |
PT Cemani Toka | Bogor, Indonesia | 72.58% | Ink manufacturing & sales |
Toka (Thailand) | Samut Prakan, Thailand | 49.00% (consolidated) | Sales |
Zhejiang Dike Toka Fine Chemical (浙江迪克東華精細化工) | Jiaxing, Zhejiang, China | 100% | Precision dispersions plant; ¥3,405M intragroup loan |
T&K TOKA U.S.A., Inc. | Illinois, USA | 100% | US holding/sales; ¥641M loan |
Van Son Holland Ink Corp. of America | Illinois, USA | 100% (indirect) | Ink manufacturing; ¥894M loan |
Midwest Ink Co. | Illinois, USA | 100% (indirect) | Ink |
Hangzhou Toka Ink Co., Ltd. | Hangzhou, China | 33.50% → ≈29.90% after Nov 2023 sale (derived) | Equity-method associate; STAR Market-listed |
Sanwa Gosei | Kaohsiung, Taiwan | 37.65% | Equity-method associate |
Seven other associates | Various | — | Not individually disclosed (includes Bangladesh and Saudi JVs historically) |
Income Statement and Margin Analysis (%)
| Metric | FY3/2019 | FY3/2020 | FY3/2021 | FY3/2022 | FY3/2023 |
|---|---|---|---|---|---|
Revenue (JPY Mn) | 49,638 | 48,217 | 42,205 | 44,456 | 43,667 |
Gross profit (JPY Mn, derived from reported gross margin) | 8,836 | 8,824 | 7,808 | 8,402 | 7,598 |
Operating income (JPY Mn) | 368 | 546 | 198 | 228 | 424 |
EBITDA (JPY Mn, EDINET DB calc.) | 2,938 | 2,914 | 2,274 | 2,354 | 2,679 |
Ordinary income / pre-tax proxy (JPY Mn) | 1,095 | 1,293 | 1,088 | 1,992 | 1,853 |
Net income attributable to owners (JPY Mn) | 627 | 158 | 1,323 | 2,651 | 1,107 |
EPS basic (JPY) | 26.7 | 6.7 | 58.4 | 117.6 | 49.3 |
Dividend per share (JPY) | 34 | 34 | 15 | 40 | 40 |
Gross margin (%) | 17.8 | 18.3 | 18.5 | 18.9 | 17.4 |
Operating margin (%) | 0.7 | 1.1 | 0.5 | 0.5 | 1.0 |
EBITDA margin (%, derived) | 5.9 | 6.0 | 5.4 | 5.3 | 6.1 |
Net margin (%) | 1.3 | 0.3 | 3.1 | 6.0 | 2.5 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Per-Share Data
| Metric (JPY Mn) | 9M to Dec 2022 | 9M to Dec 2023 | FY3/2024 original forecast | FY3/2024 revised forecast (27 Nov 2023) |
|---|---|---|---|---|
Revenue | 33,530 | 34,317 | 45,500 | 45,500 |
Operating income | 505 | 770 | 900 | 900 |
Ordinary income | 2,205 | 2,289 | 2,600 | 2,600 |
Net income | 1,517 | 1,985 | 1,500 | 1,920 |
EPS (JPY) | 67.5 | 88.3 | 66.77 | 85.46 |
Balance Sheet and Margin Analysis (%)
| Metric | FY3/2019 | FY3/2020 | FY3/2021 | FY3/2022 | FY3/2023 |
|---|---|---|---|---|---|
Total assets (JPY Mn) | 65,888 | 67,950 | 67,435 | 70,306 | 67,845 |
Cash and deposits (JPY Mn) | 4,857 | 6,534 | 6,315 | 6,245 | 2,828 |
Interest-bearing debt (JPY Mn) | 6,528 | 10,491 | 9,361 | 8,248 | 5,818 |
Net debt (JPY Mn) | 1,671 | 3,957 | 3,046 | 2,003 | 2,990 |
Net assets / equity (JPY Mn) | 44,293 | 42,957 | 44,743 | 48,296 | 49,124 |
Current assets (JPY Mn) | 31,483 | 33,814 | 31,161 | 31,341 | 28,651 |
Current liabilities (JPY Mn, derived from current ratio) | 17,394 | 18,997 | 17,605 | 18,436 | 15,742 |
Working capital (JPY Mn, derived) | 14,089 | 14,817 | 13,556 | 12,905 | 12,909 |
Inventories (JPY Mn) | 7,557 | 8,025 | 7,598 | 7,955 | 8,341 |
Retained earnings (JPY Mn) | 42,309 | 41,668 | 40,428 | 42,629 | 42,607 |
Equity ratio (%) | 66.6 | 62.5 | 65.6 | 68.0 | 71.7 |
BPS (JPY) | 1,866.4 | 1,805.7 | 1,965.7 | 2,121.1 | 2,172.2 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansCash Flow
| Metric | FY3/2019 | FY3/2020 | FY3/2021 | FY3/2022 | FY3/2023 |
|---|---|---|---|---|---|
Operating cash flow (JPY Mn) | 3,010 | 2,527 | 3,227 | 2,295 | 2,108 |
Investing cash flow (JPY Mn) | -1,458 | -3,484 | -772 | -971 | -1,747 |
Financing cash flow (JPY Mn) | -1,114 | 2,707 | -2,643 | -1,725 | -3,981 |
Free cash flow, OCF + ICF (JPY Mn) | 1,552 | -957 | 2,455 | 1,324 | 361 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY3/2019 | FY3/2020 | FY3/2021 | FY3/2022 | FY3/2023 |
|---|---|---|---|---|---|
ROE (%) | 1.4 | 0.4 | 3.1 | 5.8 | 2.3 |
ROA (%) | 1.0 | 0.2 | 2.0 | 3.8 | 1.6 |
ROIC (%, EDINET DB calc.) | 0.8 | 1.2 | 0.4 | 0.5 | 0.8 |
Current ratio (%) | 181 | 178 | 177 | 170 | 182 |
Debt to equity (x) | 0.15 | 0.24 | 0.21 | 0.17 | 0.12 |
Net debt to EBITDA (x, derived) | 0.57 | 1.36 | 1.34 | 0.85 | 1.12 |
Asset turnover (x, derived) | 0.75 | 0.71 | 0.63 | 0.63 | 0.64 |
Financial leverage (x) | 1.49 | 1.58 | 1.51 | 1.46 | 1.38 |
Dividend payout (%) | 127.3 | 507.5 | 25.7 | 34.0 | 81.2 |
Revenue by Region (%) and Revenue by Region
| Metric | FY3/2022 | FY3/2023 |
|---|---|---|
Overseas sales ratio (%) | 35.2 | 37.8 |
Overseas revenue (JPY Mn, derived) | 15,649 | 16,506 |
Japan revenue (JPY Mn, derived) | 28,807 | 27,161 |
Region Overview
| Region | Operations | Trajectory |
|---|---|---|
Japan | Saitama and Shiga plants plus branch production (Chiba, Nagoya, Osaka, Fukuoka) | Declining; branch network repeatedly consolidated (2020, 2022, 2024) |
China | Zhejiang dispersion plant (consolidated); Hangzhou Toka Ink (≈30% associate) | Associate strong; Zhejiang in ramp-up/loss phase (¥3.4bn intragroup loan) |
Korea | Korea Special Ink (115 employees) | Stable |
Southeast Asia | Indonesia (266 employees), Thailand | Growth markets for packaging |
North America | Van Son USA, Midwest Ink (Illinois) | Sub-scale; supported by intragroup loans |
Europe | Van Son B.V. liquidated Oct 2022 | Exited |
Russia / Iran | Orders from these countries had to be cancelled as a Bain tender condition | Exited (2023) |
Per-Share Data and Valuation Multiples (x)
| Metric | FY3/2019 | FY3/2020 | FY3/2021 | FY3/2022 | FY3/2023 |
|---|---|---|---|---|---|
Year-end share price (JPY, derived = PER × EPS) | 926 | 706 | 853 | 894 | 1,075 |
P/E at year-end (x) | 34.7 | 105.3 | 14.6 | 7.6 | 21.8 |
P/B at year-end (x) | 0.50 | 0.39 | 0.43 | 0.42 | 0.49 |
Dividend yield (%) | 3.66 | 4.82 | 1.76 | 4.50 | 3.72 |
Share Price & Returns
| Period | Return |
|---|---|
≈1-year (from ¥1,075, Mar 2023) | +31% |
≈3-year (from ¥853, Mar 2021) | +65% |
≈5-year (from ¥926, Mar 2019) | +52% |
Per-Share Data
| Metric | FY3/2019 | FY3/2020 | FY3/2021 | FY3/2022 | FY3/2023 |
|---|---|---|---|---|---|
DPS (JPY) | 34 | 34 | 15 | 40 | 40 |
Analyst Conclusions
Guidance and consensus
Management guidance: none published since privatisation. The last guidance was for FY3/2024: revenue ¥45.5bn, operating income ¥0.9bn, ordinary income ¥2.6bn, net income ¥1.92bn.
Consensus: none (no analyst coverage).
Bull case
-
Margin-recovery runway. Operating margin of 1.0% (FY3/2023) against peers at 5–6% and the company's own pre-2018 level of 5–6%. Closing even half that gap on ¥45bn of revenue would add roughly ¥1.0–1.5bn of operating profit (derived). Nine-month FY3/2024 operating income was already up 52%.
-
UV/EB structural tailwind. Leadership in UV inks and an early EB position address the fastest-growing, sustainability-driven segment of packaging print.
-
Hidden asset value. ≈29.9% of Hangzhou Toka, ¥12.7bn of investment securities and land at historical cost give the sponsor levers to deleverage and fund M&A without diluting the operating business.
Bear case
-
Structural decline outpaces reform. Revenue CAGR of −3.2% and an 18% fall from the peak suggest that core offset and publication ink volumes will keep shrinking, eroding the fixed-cost base faster than restructuring can respond.
-
Display-materials bet may disappoint. Zhejiang absorbed ¥3.4bn of intragroup loans, yet FY3/2023 CF dispersion shipments collapsed. Chinese panel-supply chains are highly price-competitive.
-
Execution and leverage risk. Leadership changed twice in about two years (Masuda → Takamizawa → Ishiai). The new governance model has no independent directors, and LBO debt adds fragility if raw-material or FX shocks recur.
Key catalysts and monitorables (next 12 months)
-
Any statutory financial-statement notice revealing FY3/2025 or FY3/2026 performance.
-
Bain-backed add-on acquisitions, especially overseas UV or packaging-ink assets.
-
Further sell-downs of the Hangzhou Toka stake or cross-shareholdings.
-
Zhejiang plant utilisation and display-market recovery.
-
EB ink commercial wins in flexible packaging.
-
Further domestic site consolidation or headcount changes.
-
Signals of a Bain exit (trade sale to a strategic such as a larger ink group, secondary sale, or relisting), typically 3–5 years after a 2024 entry, i.e. 2027–2029.
Analyst verdict
T&K TOKA is a textbook case of a Japanese mid-cap whose technological franchise outgrew its listed-company governance. The core asset is real: nearly five decades of UV-ink know-how, a claimed domestic share lead, and integrated resin and dispersion chemistry. Yet that asset earned an operating margin of about 1% and ROE of about 2–3% for five straight years. The shares traded at half of book value.
Ownership pressure built in stages:
-
activist Dalton/NAVF accumulated about 25%;
-
an MBO proposal surfaced and was withdrawn;
-
a partial tender offer failed;
-
the TSE's capital-efficiency push added a final catalyst.
The board responded with a credible process, running an independent special committee and a competitive auction. The outcome was a Bain take-private at ¥1,410 that delivered roughly 50–65% price upside to multi-year holders, though still below book value.
The investment question has therefore shifted from public-market valuation to private turnaround execution. Bain's playbook is unusually well suited to this situation:
-
an external, globally experienced CEO in Nobumasa Ishiai;
-
a sponsor-controlled board;
-
footprint consolidation, already visible in headcount and subsidiary rationalisation;
-
optional M&A funded partly by non-core assets.
The early evidence was encouraging: nine-month FY3/2024 operating income rose 52% before delisting. Nothing since then is publicly verifiable.
Our assessment is constructive but low-visibility. Upside rests on margin normalisation toward the 5–8% range, scaling of EB and next-generation UV, and monetising the Hangzhou stake. Downside rests on secular print decline, display-materials cyclicality and leverage. For counterparties such as suppliers, customers and potential acquirers, T&K TOKA should be viewed as a sponsor-owned specialty-ink platform likely to be repositioned for a strategic or financial exit within about 2027–2029. For credit and supply-chain risk, its pre-deal balance-sheet strength (71.7% equity ratio) offers some cushion. Monitor any disclosure of the acquisition debt quantum.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Background (where verified) |
|---|---|---|
Nobumasa Ishiai (石合 信正) | Representative Director, President & CEO | Formerly President & Representative Director of Cabot Japan K.K. (US specialty chemicals). Earlier: Senior Executive Officer and CEO of the Japan/Asia LifeScience business group at Arysta LifeScience; SVP of Invensys Climate Controls Asia-Pacific and President & CEO of Ranco Japan; COO/President of GE Polymerland Japan at General Electric. BA in Commerce, Keio University (GLOBIS Insights profile). Author of books on bringing "foreign-company speed" into Japanese firms. Appointment date not publicly disclosed. |
Yuji Takei (竹井 友二) | Director | — |
Shoji Suekane (末包 昌司) | Director | — |
Yuriro Ogawa (小川 由理郎) | Director | — |
Kei Komachi (小町 景) | Corporate Auditor (Kansayaku) | — |
Satoshi Ueyama (上山 聡) | Corporate Auditor | — |
Kazuhiko Nakama (中間 和彦) | Managing Executive Officer, CTO | Born 1967. In FY3/2023 he was Managing Director heading the Ink Business HQ. |
Hideaki Sekine (関根 秀明) | Managing Executive Officer, CFO | Born 1968. In FY3/2023 he was Managing Director, head of Management HQ and Finance Dept. |
Board of Directors
| Name | Title | Born | Tenure / notes |
|---|---|---|---|
Akihiro Takamizawa | Representative Director, President | 1,970 | Joined 1994. General Manager of Hangzhou Toka Ink from 2008. Director from June 2021. Not on the current board. |
Kazuhiko Nakama | Managing Director, Ink Business HQ | 1,967 | Owned 13,000 shares |
Hideaki Sekine | Managing Director, Management HQ & Finance | 1,968 | — |
Kenji Otaka | Outside Director (A&SC member) | 1,952 | Since June 2015; Southeast Asia business expertise |
Satoshi Noguchi (野口 郷司) | Outside Director (A&SC chair; Nomination Committee chair) | 1,952 | Since June 2017; former listed-company executive |
Koichi Hanabusa | Outside Director (A≻ Remuneration Committee chair) | 1,958 | Certified public accountant |
Hideaki Kimura | Outside Director (A&SC) | 1,962 | Since June 2022; attorney; former Vice-President of the Tokyo Bar Association |
Governance Detail
| Category | Headcount | Total (JPY Mn) | Fixed | Performance cash | Non-monetary (stock) |
|---|---|---|---|---|---|
Internal directors | 6 | 177 | 150 | 26 | 40 |
Outside directors | 8 | 39 | 39 | 0 | 0 |
Major Shareholders
| Holder | Stake |
|---|---|
Dalton Investments, Inc. (Dalton LLC reported as "other affiliated company", 19.28% voting) | 19.13% |
Master Trust Bank of Japan (trust a/c) | 7.42% |
Koshibi (Masuda family asset vehicle) | 4.65% |
Mizuho Bank (incl. 4.34% retirement-benefit trust via Mizuho Trust) | 4.36% |
NAVF PLC | 3.98% |
Meiji Yasuda Life | 3.34% |
Mikako Ueda | 3.29% |
Azuchi Masuda | 3.25% |
Yoshikatsu Masuda | 3.21% |
Hiromi Masuda | 2.84% |
Asuka Masuda | 2.55% |
NAVF Select LLC | 1.49% |
Competitive Landscape
Competitors by Segment
| Business line | Competitor | HQ | Notes |
|---|---|---|---|
Printing inks (global) | DIC Corporation (incl. Sun Chemical) | Japan | World's largest ink group. |
Printing inks | artience Co., Ltd. (formerly Toyo Ink SC Holdings) | Japan | FY12/2025 revenue ≈¥350bn (the-shashi.com, from Yuho) |
Printing inks | Sakata INX Corporation | Japan | FY12/2024 revenue ¥245,570M, OI ¥13,161M. FY12/2025 revenue ≈¥257.7bn, OI ≈¥15.2bn. Overseas share 74.5% (FY12/2025). |
Printing inks | Flint Group | Luxembourg/Europe | — |
Printing inks | Siegwerk Druckfarben | Germany | — |
Printing inks | hubergroup | Germany | — |
UV / screen / special inks | Teikoku Printing Inks Mfg. | Japan | — |
UV / special inks | Jujo Chemical | Japan | — |
China inks | Hangzhou Toka Ink (also an affiliate) and domestic Chinese makers | China | Simultaneously partner and competitor in China |
Colour-filter dispersions | Toyocolor (artience group), Mikuni Color, other pigment-dispersion makers | Japan | — |
Epoxy hardeners / latent curing agents | Evonik, Mitsubishi Chemical, ADEKA, Ajinomoto Fine-Techno | Global/Japan | — |
Peer Comparison FY2012
| Metric | T&K TOKA (FY3/2023) | Sakata INX (FY12/2024) | Sakata INX (FY12/2025) | artience (FY12/2025) |
|---|---|---|---|---|
Revenue (JPY Bn) | 43.7 | 245.6 | 257.7 | 350.0 |
Revenue growth (%) | -1.8 | 7.5 | 4.9 | — |
Operating margin (%) | 1.0 | 5.4 | 5.9 | — |
R&D intensity (%) | 2.1 | — | — | — |
ROE (%) | 2.3 | — | 10.0 | — |
Recent Developments
*Disclosure caveat. The 18 months to October 2026 fall entirely within private ownership. The company publishes almost no material news beyond website updates.
Guidance revisions, litigation, layoffs or new contract wins after



